Welcome to The Hub
Dive into our resources hub—your go-to destination for insights, tools, and expertise. From white papers to case studies, webinars to industry guides, it’s all here to help you navigate the challenges of scaling cell therapy manufacturing. Explore, learn, and lead with confidence.
Cellular Origins and Cytiva are collaborating to deliver automated robotic manufacturing capabilities for cell and gene therapies
Cellular Origins and Fresenius Kabi sign development agreement for scalable automation of CGT manufacturing
How to de-risk cell & gene therapy manufacturing
Manufacturing Chemist: Why CGT manufacturers should automate the production process
Cellular Origins and 3P innovation collaborate to accelerate industrialisation of CGT manufacturing
Cellular Origins Appoints Geoffrey Hodge as Non-Executive Director
Cellular Origins Acquires ACTIA Platform IP to enhance automated cell therapy manufacturing
Cellular Origins and Cell and Gene Therapy Catapult collaborate to demonstrate universal automation of CGT manufacturing
Meet Szer Ming Lee, Head of Software at Cellular Origins
Cellular Origins awarded highly commended in ‘The Award for Innovation’ at this year’s Cambridge Independent Science and Technology Awards
Cellular Origins, a TTP Company, appoints Peter Crossley as Chief Operating Officer
Meet Jason Jones, Global Business Development Lead at Cellular Origins
Cellular Origins, a TTP Company, establishes Advisory Board of global industry leaders
BioPharm International: Automation Aids CGT Production
Drug Digest: Improving Aseptic Processing and Manufacturing Needs
BioPharm International: Expanding the Emerging Therapeutic Horizon
Advanced Therapies Week: Building Infrastructure and Capacity Panel Session
Cellular Origins launches Constellation™, its configurable robotic platform to enable scalable manufacture of advanced therapies
Cellular Origins partners with ScaleReady to simplify, standardise, and automate cell therapy manufacturing
Labiotech: Where is innovation needed in cell therapy?
Beyond Biotech podcast 36: Bio-Europe Spring and Cellular Origins
GEN: Cell and Gene Therapy Scale-Up Challenges
Constellation featured in Science: Configurable Robotic Platform For Advanced Therapy Manufacturing
No More Sleepwalking: New Mindsets for Manufacturing Cell and Gene Therapies at Commercial Scale
TTP introduces Cellular Origins, a TTP Company focussed on delivering scalable manufacture of cell and gene therapies
What failure rate are we willing to accept in cell therapy manufacture? Insights from medical device development
UK Innovation Corridor ‘critical’ to development of cell and gene therapy, TTP plc summit told
Video Interview: Talking Cell Therapy Trends – Edd Stone of TTP explains how the industry is overcoming the manufacturing challenges associated with cell therapies
ISCT 2023 Paris Annual Meeting
How do we ensure that not only the rich benefit from cell and gene therapy?
Predicting failure rates in cell therapy manufacturing: is one in a million good enough?
Cell Therapy Scaling: Beyond the Biology
The Role of Automation in Industrializing Cell Therapy Manufacturing
Key Takeaways from Advanced Therapies Europe
Ready to transform your cell therapy manufacturing?
Take the first step to scalable, efficient, and future-ready cell therapy manufacturing. Complete the form below and one of our experts will be in touch.
Let’s shape the future together.
Ready to transform your cell therapy manufacturing?
Take the first step to scalable, efficient, and future-ready cell therapy manufacturing. Complete the form below and one of our experts will be in touch.
Let’s shape the future together.